Skip to main content
. 2014 Sep 4;473(3):1155–1164. doi: 10.1007/s11999-014-3925-y

Table 3.

Effect of steroid by dilution, overall

Dilution Steroid Mean SD p value* Pairwise comparisons
0.00% Beta 1.03 0.12 0.204 Beta vs Dex (DMOD = 0.035; 95% CI, −0.014–0.085)
Dex 1.00 0.07 Depo vs Beta (DMOD = 0; 95% CI, −0.05–0.05)
Depo 1.03 0.09 Beta vs Kenalog (DMOD = 0.009; 95% CI, −0.04–0.059)
Kenalog 1.02 0.09 Depo vs Dex (DMOD = 0.036; 95% CI, −0.014–0.085)
Kenalog vs Dex (DMOD = 0.026; 95% CI, −0.024–0.076)
Depo vs Kenalog (DMOD = 0.01; 95% CI, −0.04–0.059)
3.125% Beta 0.74 0.12 < 0.0001 Dex vs Beta (DMOD = 0.123; 95% CI, 0.066–0.179; p < 0.001)
Dex 0.86 0.09 Beta vs Depo (DMOD = 0.001; 95% CI, −0.055–0.057; p > 0.999)
Depo 0.74 0.08 Kenalog vs Beta (DMOD = 0.078; 95% CI, 0.022–0.135; p = 0.003)
Kenalog 0.82 0.08 Dex vs Depo (DMOD = 0.124; 95% CI, 0.068–0.18; p < 0.001)
Dex vs Kenalog (DMOD = 0.044; 95% CI, −0.012–0.101; p = 0.17)
Kenalog vs Depo (DMOD = 0.08; 95% CI, 0.023–0.136; p = 0.002)
6.25% Beta 0.27 0.11 < 0.0001 Dex vs Beta (DMOD = 0.471; 95% CI, 0.388–0.553; p < 0.001)
Dex 0.74 0.14 Depo vs Beta (DMOD = 0.268; 95% CI, 0.186–0.351; p < 0.001)
Depo 0.54 0.11 Kenalog vs Beta (DMOD = 0.37; 95% CI, 0.288–0.453; p < 0.001)
Kenalog 0.64 0.10 Dex vs Depo (DMOD = 0.203; 95% CI, 0.12–0.285; p < 0.001)
Dex vs Kenalog (DMOD = 0.101; 95% CI, 0.018–0.183; p = 0.011)
Kenalog vs Depo (DMOD = 0.102; 95% CI, 0.02–0.184; p = 0.01)
12.5% Beta 0.02 0.03 < 0.0001 Dex vs Beta (DMOD = 0.505; 95% CI, 0.427–0.583; p < 0.001)
Dex 0.53 0.12 Depo vs Beta (DMOD = 0.288; 95% CI, 0.21–0.366; p < 0.001)
Depo 0.31 0.11 Kenalog vs Beta (DMOD = 0.434; 95% CI, 0.356–0.512; p < 0.001)
Kenalog 0.45 0.01 Dex vs Depo (DMOD = 0.217; 95% CI, 0.139–0.295; p < 0.001)
Dex vs Kenalog (DMOD = 0.071; 95% CI, −0.006–0.149; p = 0.083)
Kenalog vs Depo (DMOD = 0.146; 95% CI, 0.068–0.224; p < 0.001)
25.0% Beta 0.00 0.00 < 0.0001 Dex vs Beta (DMOD = 0.302; 95% CI, 0.246–0.359; p < 0.001)
Dex 0.30 0.08 Depo vs Beta (DMOD = 0.122; 95% CI, 0.066–0.179; p < 0.001)
Depo 0.12 0.06 Kenalog vs Beta (DMOD = 0.177; 95% CI, 0.121–0.234; p < 0.001)
Kenalog 0.18 0.11 Dex vs Depo (DMOD = 0.18; 95% CI, 0.123–0.236; p < 0.001)
Dex vs Kenalog (DMOD = 0.125; 95% CI, 0.068–0.181; p < 0.001)
Kenalog vs Depo (DMOD = 0.055; 95% CI, −0.001–0.112; p = 0.059)
50.0% Beta 0.00 0.00 < 0.0001 Dex vs Beta (DMOD = 0.198; 95% CI, 0.167–0.23; p < 0.001)
Dex 0.20 0.06 Depo vs Beta (DMOD = 0.006; 95% CI, −0.025–0.037; p = 0.953)
Depo 0.01 0.02 Kenalog vs Beta (DMOD = 0.032; 95% CI, 0.001–0.063; p = 0.045)
Kenalog 0.03 0.05 Dex vs Depo (DMOD = 0.192; 95% CI, 0.161–0.223; p < 0.001)
Dex vs Kenalog (DMOD = 0.167; 95% CI, 0.135–0.198; p < 0.001)
Kenalog vs Depo (DMOD = 0.026; 95% CI, −0.006–0.057; p = 0.145)
75.0% Beta 0.00 0.00 < 0.0001 Dex vs Beta (DMOD = 0.091; 95% CI, 0.066–0.116]; p < 0.001)
Dex 0.09 0.06 Depo vs Beta (DMOD = 0; 95% CI, −0.025–0.025; p > 0.999)
Depo 0.00 0.00 Beta vs Kenalog (DMOD = 0; 95% CI, −0.025–0.025; p > 0.999)
Kenalog 0.00 0.00 Dex vs Depo (DMOD = 0.091; 95% CI, 0.066–0.116; p < 0.001)
Dex vs Kenalog (DMOD = 0.091; 95% CI, 0.066–0.116; p < 0.001)
Depo vs Kenalog (DMOD = 0; 95% CI, −0.025–0.025; p > 0.999)
100.0% Beta 0.00 0.00 < 0.0001 Dex vs Beta (DMOD = 0.005; 95% CI, 0–0.009; p = 0.024)
Dex 0.00 0.01 Beta vs Depo (DMOD = 0; 95% CI, −0.004–0.004; p > 0.999)
Depo 0.00 0.00 Beta vs Kenalog (DMOD = 0; 95% CI, −0.004–0.004; p > 0.999)
Kenalog 0.00 0.00 Dex vs Depo (DMOD = 0.005; 95% CI, 0–0.009; p = 0.024)
Dex vs Kenalog (DMOD = 0.005; 95% CI, 0–0.009; p = 0.024)
Depo vs Kenalog (DMOD = 0; 95% CI, −0.004–0.004; p > 0.999)

Beta = betamethasone; Dex = dexamethasone; Depo = methylprednisolone; Kenalog = triamcinolone; DMOD = difference in mean optical density; *p value of the four-way ANOVA; pairwise comparisons performed only when the overall ANOVA test was statistically significant (p < 0.05). Pairwise comparison p values were adjusted with the Tukey method to guard against Type I error.